Compugen Ltd. (CGEN) vs Cartesian Therapeutics, Inc. (RNAC)
A side-by-side comparison of Compugen Ltd. and Cartesian Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CGEN
Compugen Ltd.
$2.24HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
RNAC
Cartesian Therapeutics, Inc.
$6.92HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
Total return — CGEN vs RNAC
growth of $100 · dividends reinvested · last 10yCGEN -63.7% (-9.6%/yr)RNAC -98.4% (-33.9%/yr)CGEN compounded faster over this window
Log scale — wide-divergence pair
CGEN RNAC
CGEN vs RNAC: by the numbers
- •CGEN is the larger company ($211M vs $203M market cap).
- •CGEN is profitable (47.55% net margin) while RNAC runs a net loss (-10422.48%).
- •CGEN grew revenue faster over the past five years (105.91% vs -50.01% CAGR).
Metrics side by side
Valuation
| Metric | CGEN | RNAC |
|---|---|---|
| P/E ratio | 5.95 | N/A |
| P/S ratio | 2.86 | 137.71 |
| P/B ratio | 2.38 | N/A |
Profitability
| Metric | CGEN | RNAC |
|---|---|---|
| Gross margin | 86.89% | 100.00% |
| Operating margin | 40.94% | -3099.93% |
| Net margin | 47.55% | -10422.48% |
| ROE | 39.66% | N/A |
| ROIC | 26.14% | -33.10% |
Growth (annualized)
| Metric | CGEN | RNAC |
|---|---|---|
| Revenue CAGR (5Y) | 105.91% | -50.01% |
| Total return CAGR (5Y) | -18.39% | -44.03% |
Frequently asked
- Which has grown faster, CGEN or RNAC?
- Over the past five years, CGEN grew revenue faster — CGEN at a 105.91% CAGR versus RNAC at -50.01%.
- Is CGEN or RNAC more profitable?
- CGEN runs the higher net margin — CGEN at 47.55% versus RNAC at -10422.48%.
- How have CGEN and RNAC total returns compared?
- Over the past 10 years, CGEN delivered -9.42% and RNAC delivered -33.65% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Compugen P/E ratioCompugen ROECartesian Therapeutics ROECompugen operating marginCartesian Therapeutics operating marginCompugen revenue growthCartesian Therapeutics revenue growthCompugen free cash flowCartesian Therapeutics free cash flow
Compugen & Cartesian Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.